Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,753Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1 Canaglu

02 6Canaglu

03 10Canalia

04 1Invokana / Invokamet

05 11Invokana/Invokamet

06 1Royalty From Invokana

07 7Royalty from Invokana

PharmaCompass

01

Brand Name : Canalia

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Canalia

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 137

2019 Revenue in Millions : 112

Growth (%) : 22

blank

02

Brand Name : Invokana/Invokamet

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Invokana/Invokamet

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 795

2019 Revenue in Millions : 735

Growth (%) : 8

blank

03

Brand Name : Invokana/Invokamet

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Invokana/Invokamet

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 795

2019 Revenue in Millions : 735

Growth (%) : 8

blank

04

Brand Name : Canaglu

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Canaglu

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 95

2019 Revenue in Millions : 75

Growth (%) : 26

blank

05

Brand Name : Canalia

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Canalia

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 139

2020 Revenue in Millions : 136

Growth (%) : 11

blank

06

Brand Name : Royalty from Invokana

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Royalty from Invokana

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 86

2019 Revenue in Millions : 80

Growth (%) : 7

blank

07

Brand Name : Canalia

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Canalia

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 80

2019 Revenue in Millions : 69

Growth (%) : 16

blank

08

Brand Name : Royalty from Invokana

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Royalty from Invokana

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 56

2020 Revenue in Millions : 85

Growth (%) : -29

blank

09

Brand Name : Canalia

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Canalia

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 84

2020 Revenue in Millions : 79

Growth (%) : 15

blank

10

Brand Name : Invokana/Invokamet

Canagliflozin

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Invokana/Invokamet

arrow
The Pharmacy Technology
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 563

2020 Revenue in Millions : 795

Growth (%) : -29

blank